pharmaphorum
MAY 21, 2021
When it comes to ultra-rare diseases, the smaller the patient population, the bigger the challenges. As a global commercial biopharmaceutical company pioneering therapies for ultra-rare diseases, PTC Therapeutics is familiar with the challenges. The company prides itself on a patient-centric approach to treatment but there can be significant hurdles in patients accessing potentially life-changing treatments.
Outsourcing Pharma
MAY 17, 2021
According to a leader from industrial AI specialist AspenTech, AI can help avoid costly maintenance interruptions by predicting when upkeep is needed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Mirror
MAY 19, 2021
Terrassa (Barcelona). Azbil Telstar announces the appointment of Rashedi Hassan as a Sales & Marketing Manager of the subsidiary of the company in Dhaka, Bangladesh. From 14th February 2021, Rashedi Hassan focuses his responsibility on developing extensive marketing and sales plan to strengthen the Telstar brand position in the local pharmaceutical market and to promote the presence and distribution of Telstar branded Life Sciences service & product solutions in the region, particularly
Druggist
MAY 16, 2021
Paracetamol is one of the most purchased over the counter painkillers. It is still one of the most prescribed drugs in the UK. Over the counter paracetamol is available in different forms, commonly sold as tablets. Today, I will answer the main question of this post: Can you crush paracetamol? Summary: . What is paracetamol? . Paracetamol: availability of different forms.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 19, 2021
Just over a year ago, hi.health launched an app that takes the legwork out of submitting reimbursement claims to private health insurers. Now, the startup has taken another leap forward, settling users bills immediately. . Fredrik Debong. The addition to the hi.health app acts as a digital health expense account, according to the company’s co-founder and chief scientific officer Fredrik Debong, who was a co-founder of diabetes management app mySugr.com, which was snapped up by Roche in 201
Outsourcing Pharma
MAY 21, 2021
The two tech-focused firms are joining forces to work on technology solutions aimed at improving patient recruitment and enrollment for various studies.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Infectious Pharmacist
MAY 19, 2021
Photo by Pixabay on Pexels.com. Many of my friends are concerned about starting “normal activities” after vaccination, the possibility of breakthrough infections, and the recent CDC guidance that fully vaccinated persons can go “maskless” in most situations. Today my goal is to cover those topics. This is a long post. What is a person’s risk of COVID-19 infection if they have been fully vaccinated?
pharmaphorum
MAY 20, 2021
NICE has rejected Johnson & Johnson’s oral prostate cancer drug Erleada (apalutamide) in patients with hormone-relapsed or hormone sensitive disease in first draft guidance. The cost-effectiveness body is assessing Erleada , plus androgen deprivation therapy (ADT), for prostate cancer in adults who have hormone-relapsed non-metastatic disease at high risk of metastasising and hormone-sensitive metastatic disease.
Outsourcing Pharma
MAY 18, 2021
In this third part of a series on the state of clinical research, the acting FDA commissioner talks about possible pathways to improving the infrastructure.
Pharma Mirror
MAY 21, 2021
Nuvera are experts in optimizing the design and build of seamless patient and HCP treatment experiences. This expertise will enhance Ashfield Engage’s Patient Solutions capabilities and create an end-to-end strategic offering across their client’s product lifecycles. Following the acquisition, Ashfield Engage and Nuvera will offer integrated specialist support and services including late-phase clinical trial experience, implementation and post-commercialization satisfaction benchmarking and serv
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
MAY 17, 2021
Head of Digital Customer Interactions for North America. Ipsen Biopharmaceuticals. A passionate and innovative Senior Commercial Leader with a 25+ year career in consumer, medical device and Pharma/Bio-tech, Paul has his finger on the pulse of Digital Transformation with a solid understanding of Customer Engagement. His experience in operations as well as both sales and marketing gives him a unique perspective on the integration of technology that increases customer engagements and the user expe
pharmaphorum
MAY 20, 2021
All seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will see whether they can be used as a third booster dose to protect against new variants. . The Cov-Boost trial is thought to be the first in the world to try to generate data on the value of booster doses in protecting people against COVID-19, and is being led by University Hospital Southampton NHS Foundation Trust.
Outsourcing Pharma
MAY 20, 2021
According to a leader from Saama Technologies, keeping competitive in the face of technology evolution requires staff that can keep up with the changes.
Pharma Mirror
MAY 20, 2021
For researchers, the challenges are endless and the journey is anything but easy and straightforward. Every year, the pharmaceutical industry of the U.K alone plays a crucial part in developing new drugs that deliver numerous health benefits. Many aim to resolve critical diseases that threaten mankind. A vast majority of these drugs are expensive and there is no doubt what financial strain they put on the ever-increasing healthcare costs of the federal government as well as the private sector.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Med Ed 101
MAY 19, 2021
In the ambulatory care and geriatrics space, I see magnesium supplements used on a fairly frequent basis in practice. Here are a few magnesium clinical pearls that I’ve picked up along the way. Drugs That Cause Magnesium Deficiency There are a few no doubters that you need to remember when it comes to hypomagnesemia. In […]. The post Magnesium Clinical Pearls appeared first on Med Ed 101.
pharmaphorum
MAY 20, 2021
Create a positive working culture for the UK’s researchers, or watch the country’s standing as an innovation leader crumble, says new report. From the Oxford vaccine to the RECOVERY trial, all eyes have been on the triumph of British science in recent months. But future success is at risk if we do not create a culture that inspires and supports the next generation of researchers, says a report from the Russell Group of universities.
Outsourcing Pharma
MAY 21, 2021
A representative from the digital experience management firm discusses how improving the quality of tech interactions with patients can elevate results.
Pharma Times
MAY 19, 2021
Collaboration will utilise Mestag’s specialist fibroblast subpopulation biology platform to identify novel therapeutic targets
Med Ed 101
MAY 16, 2021
You will see antiarrhythmics used in clinical practice. They are typically prescribed by cardiovascular specialists, but we wanted to provide an antiarrhythmic comparison chart because as a healthcare professional, you still need to monitor for risks and drug interactions associated with these medications. Patients can develop arrhythmias through a variety of cardiac and non-cardiac factors. […].
pharmaphorum
MAY 17, 2021
Criminals have launched a ransomware attack against the Department of Health in Ireland, shortly after a similar cyberattack shut down much of the IT infrastructure at the Health Service Executive (HSE). . The Irish government confirmed the latest attempt yesterday, two days after the HSE was hit by a new variant of the Conti ransomware virus – thought to be run by Russia-based criminal group Wizard Spider – that was able to evade its security protocols.
Outsourcing Pharma
MAY 19, 2021
The virtual event (scheduled June 22-24) will feature presentations from Bayer, Merck, GSK, Novartis, Takeda, FDA, WHO, and other notable organizations.
Pharma Times
MAY 20, 2021
If approved, up to 2,000 children with CF would be eligible for treatment with the drug
The deprescribing.org Blog
MAY 20, 2021
Greetings, deprescribers! Today we come to you with a special literature blog post highlighting 10 key deprescribing articles that together provide an overview of the field of deprescribing – covering the mindset of deprescribing, the complexity of and challenges related to deprescribing in clinical practice, the development and testing of deprescribing interventions, and perspectives of future deprescribing research.
pharmaphorum
MAY 18, 2021
Digital therapy specialist Healios has raised £7 million in new financing that will be used to expand its suite of mental health services, at a time when demand is soaring in the NHS. The London-based company has developed a virtual care platform that delivers a range of services targeted at children and young people with conditions such as anxiety, low mood, autism and attention-deficit hyperactivity disorder (ADHD), as well as their families.
Outsourcing Pharma
MAY 20, 2021
An executive from the virtual research organization discusses the importance of advaincing studies through innovation and a patient-centric approach.
Pharma Times
MAY 20, 2021
Cost-effectiveness estimates have fallen above the threshold because of uncertain trial evidence
pharmaphorum
MAY 17, 2021
Experts from Vynamic discuss their vision for a future where patients are at the heart of medicine reimbursement in Europe – and provide actionable steps for achieving this. This article appears in full in our digital magazine Deep Dive: Market Access 2021. Read below for a sneak-peak: The reimbursement landscape in Europe is complex. There are different models, medicines are evaluated in different ways and the timelines for approval vary widely.
pharmaphorum
MAY 19, 2021
Pharmaceutical drug success rests on being able to achieve market access. Brands are facing increasing pressure to demonstrate strong value propositions in increasingly crowded therapeutic areas. However, value can mean different things to different payers. In this article, Cecilie Alstad, senior analyst at Research Partnership, discusses how an approach established in the world of marketing and commercial strategy could be the key to significantly improving pharma’s payer engagement.
pharmaphorum
MAY 20, 2021
Exscientia has signed up another big pharma partner for its artificial intelligence (AI) based drug discovery platform, this time attracting a $50 million upfront buy-in from Bristol-Myers Squibb. . BMS wants to harness Exscientia’s tech to discover small-molecule drugs across a range of therapeutic categories – including immunology and oncology – and is promising another $125 million in near- and mid-term milestones to the project if all goes well.
pharmaphorum
MAY 18, 2021
Canadian biotech Medicago has the data it was hoping for from a phase 2 trial of its COVID-19 vaccine, partnered with GlaxoSmithKline, and is now hoping to have phase 3 data available “by early summer.” The interim phase 2 results show that two doses of the plant-derived jab stimulated neutralising antibody levels that are around 10 times higher than those in a panel of sera from patients recovering from COVID-19, with a similar response seen in adults and the elderly.
pharmaphorum
MAY 21, 2021
GlaxoSmithKline has sold its entire stake in its respiratory partner Innoviva, raising $392 million and simplifying its business ahead of a split into two. GSK is pushing ahead with a split into an innovative drugs business and a consumer healthcare firm, while the spectre of activist investor Elliott Management hangs over it. The fund run by billionaire Paul Singer has bought a significant stake in GSK and is notorious for demanding and often enforcing significant changes in the companies it in
pharmaphorum
MAY 21, 2021
UK digital health firm Vinehealth has won a CE mark for a mobile app that helps cancer patients manage their medications and care, as well as a sister web-based app aimed at clinicians. . The Vinehealth Cancer Companion – originally developed by neurologist Dr Rayna Patel and Georgina Kirby, the company’s co-founders – uses behavioural science and artificial intelligence to help cancer patients track, manage and understand their care.
pharmaphorum
MAY 19, 2021
The UK government’s Online Safety Bill has been a hot and contentious topic of discussion over the past year, but last week it was finally announced and included in the Queen’s Speech. For Mental Health Awareness Month, Tim Barker looks at why a new bill could be a step towards digitally safe mental health support. . There’s been a heavy reliance on technology during the pandemic for home schooling, home working and some semblance of social connection.
pharmaphorum
MAY 18, 2021
Speculation is mounting GlaxoSmithKline’s CEO Emma Walmsley may pay the price for the company’s lacklustre performance, after the dreaded activist investor Elliott Management built a stake in the struggling pharma. GSK is fast becoming thought of as the UK’s other pharma company following Pascal Soriot’s successful turnaround of AstraZeneca – but according to press reports some investors are losing patience with Walmsley’s efforts to revive the firm.
Expert insights. Personalized for you.
111 
Let's personalize your content